300896.SZ
300896.SZ
CNE100004868
IMEIK
Loading chart...

Company Profile

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

Related stocks

603301.SS
603301.SS • China
ZHENDE MEDICAL CO LTD
81 CNY
3.2B USD 1Y +57.8%
688301.SS
688301.SS • China
IRAY GROUP
79.99 CNY
3.75B USD 1Y -9.8%
300677.SZ
300677.SZ • China
YKYL
49 CNY
4.8B USD 1Y +33.5%
2276.HK
2276.HK • China
CONANT OPTICAL
35.6 HKD
2.19B USD 1Y -13.4%
603087.SS
603087.SS • China
GAN&LEE PHARMACEUTICALS CO LTD
75.52 CNY
6.76B USD 1Y -0.2%
688029.SS
688029.SS • China
MICRO-TECH (NANJING) CO LTD
83.3 CNY
2.34B USD 1Y -15.2%
ANN.AX
ANN.AX • Australia
ANSELL FPO [ANN]
45.14 AUD
4.44B USD 1Y +37.4%
1066.HK
1066.HK • China
WEIGAO GROUP
3.31 HKD
1.89B USD 1Y -45.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
43.8% p.a.
Max Drawdown (5Y)
-81.8%
Sharpe Ratio (5Y)
-0.64
Beta Factor
0.60
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (43.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -81.8% in the extended horizon.
ende